hotspot -WSS

hotspot

author：leisure time 2025-09-29 03:58:55 - browse：41

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： Archived: an online chat discussing Ebola, vaccines, and a new epidemic

focus

WSS

A single Democrat is willing to weaken Medicare negotiation power

Padmanee Sharma of MD Anderson at center of lawsuit over credit

What affirmative action's end means to a medical student

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

What affirmative action's end means to a medical student

focus

hotspot

hotspot

Affirmative action in medical school literally saved lives

Gene therapy for Afghan refugees’ infant will be fully covered

Walensky prepares to leave CDC — and Congress — behind

Top private equity targets in 2023: cardiology, clinical trials, lasers

In Memoriam: Notable people who died in 2023

Medicare Advantage plans can’t deny care with AI, CMS warns

Bright Health sells Medicare Advantage business to Molina

Problems with a popular proposal to regulate AI in health care

Virginia high school admissions case could be legal follow

Trump’s hydroxychloroquine hype: a risk to my treatment and to him

Wikipedia

Padmanee Sharma of MD Anderson at center of lawsuit over credit

Top private equity targets in 2023: cardiology, clinical trials, lasers

AstraZeneca lung cancer study comes in below expectations

Fatty liver disease was alleviated by Lilly’s ‘triple

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

What’s missing from the debate over nursing home staff minimums

leisure time

focus

leisure time

explore